Aptevo Therapeutics Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.62M | 21.06M | 9.41M | 2.14M | 8.71M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.07M | 1.51M | 1.59M | 1.35M | 925.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 853.00K | 77.00K | 82.00K | 120.00K | 1.02M |
| Total Current Assets | 23.08M | 22.65M | 11.08M | 3.61M | 10.66M |
|
|
|||||
| Total Current Assets | 23.08M | 22.65M | 11.08M | 3.61M | 10.66M |
| Net Property, Plant & Equipment | 4.11M | 4.35M | 4.54M | 4.74M | 4.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 27.19M | 27.00M | 15.62M | 8.34M | 15.59M |
|
|
|||||
| Total Accounts Payable | 877.00K | 2.22M | 2.90M | 3.79M | 1.24M |
| Total Accrued Expenses | 4.31M | 1.90M | 1.04M | 472.00K | 4.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 866.00K | 800.00K | 800.00K | -- | 768.00K |
| Total Finance Division Other Current Liabilities | -- | 694.00K | 148.00K | 1.13M | -- |
| Total Other Current Liabilities | -- | 694.00K | 148.00K | 1.13M | -- |
| Total Current Liabilities | 6.05M | 5.61M | 4.89M | 5.39M | 6.21M |
|
|
|||||
| Total Current Liabilities | 6.05M | 5.61M | 4.89M | 5.39M | 6.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.76M | 3.99M | 4.21M | 4.42M | 4.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.81M | 9.60M | 9.10M | 9.82M | 10.84M |
|
|
|||||
| Common Stock & APIC | 292.50M | 286.61M | 266.71M | 252.51M | 252.33M |
| Retained Earnings | -275.12M | -269.22M | -260.19M | -253.99M | -247.58M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.38M | 17.39M | 6.52M | -1.47M | 4.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.38M | 17.39M | 6.52M | -1.47M | 4.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.38M | 17.39M | 6.52M | -1.47M | 4.76M |
|
|
|||||